血液学之外——嵌合抗原受体（CAR）T 细胞治疗皮肤与结缔组织疾病的最新认识

Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.

儿童神经母细胞瘤的免疫治疗进展：通过生物标志物指导的联合方案克服耐药

Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations.

人神经母细胞瘤组织样本 GD2 免疫荧光的逆向方法：从染色到切片

A Backwards Approach to GD2 Immunofluorescence in Human Neuroblastoma Tissue Samples: From Staining to Slicing.

我们得以建立并验证一种新方案，可在未固定的原发神经母细胞瘤组织中可靠地进行膜抗原 GD2 的免疫染色。

CAR-T 疗法治疗中枢神经系统肿瘤的进展

Advances in CAR-T therapy for central nervous system tumors.

ALK 抑制剂升高 ALK 表达并使神经母细胞瘤细胞对 ALK.CAR-T 细胞增敏

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.

建立表达神经节苷脂 GD2 的结外 NK/T 细胞淋巴瘤细胞系并进行 scRNA-seq 分析

Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.

组成型白细胞介素-7 细胞因子信号增强 Epstein-Barr 病毒特异性 T 细胞的持久性

Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.

利用 AND 逻辑门工程化 CAR-T 细胞靶向低 ALK 抗原密度神经母细胞瘤

Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells.

这些数据进一步证明了 ALK 作为神经母细胞瘤 CAR-T 细胞靶点的概念验证。